RNA-mediated displacement of an inhibitory snRNP complex activates transcription elongation

被引:111
作者
D'Orso, Ivan [1 ]
Frankel, Alan D. [1 ]
机构
[1] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA
基金
美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; CARBOXYL-TERMINAL DOMAIN; POLYMERASE-II TRANSCRIPTION; BROMODOMAIN PROTEIN BRD4; P-TEFB; HIV-1; TAT; 7SK SNRNP; TYPE-1; TRANSCRIPTION; PROCESSING FACTORS; NASCENT RNA;
D O I
10.1038/nsmb.1827
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transition from transcription initiation to elongation at the HIV-1 promoter is controlled by Tat, which recruits P-TEFb to TAR RNA to phosphorylate RNA polymerase II. It has long been unclear why the HIV-1 promoter is incompetent for elongation. We report that P-TEFb is recruited to the promoter in a catalytically inactive state bound to the inhibitory 7SK small nuclear ribonucleoprotein (snRNP), thereby preventing elongation. It also has long been believed that TAR functions to recruit Tat to the promoter, but we find that Tat is recruited to the DNA template before TAR is synthesized. We propose that TAR binds Tat and P-TEFb as it emerges on the nascent transcript, competitively displacing the inhibitory 7SK snRNP and activating the P-TEFb kinase. Recruitment of an inhibitory snRNP complex at an early stage in the transcription cycle provides a new paradigm for controlling gene expression with a noncoding RNA.
引用
收藏
页码:815 / U59
页数:8
相关论文
共 61 条
[1]   Phosphorylation of serine 2 within the RNA polymerase IIC-terminal domain couples transcription and 3′ end processing [J].
Ahn, SH ;
Kim, M ;
Buratowski, S .
MOLECULAR CELL, 2004, 13 (01) :67-76
[2]   Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription [J].
Barboric, Matjaz ;
Yik, Jasper H. N. ;
Czudnochowski, Nadine ;
Yang, Zhiyuan ;
Chen, Ruichuan ;
Contreras, Xavier ;
Geyer, Matthias ;
Peterlin, B. Matija ;
Zhou, Qiang .
NUCLEIC ACIDS RESEARCH, 2007, 35 (06) :2003-2012
[3]   The transcription-dependent dissociation of P-TEFb-HEXIMI-7SK RNA relies upon formation of hnRNP-7SK RNA complexes [J].
Barrandon, Charlotte ;
Bonnet, Francois ;
Nguyen, Van Trung ;
Labas, Valerie ;
Bensaude, Olivier .
MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (20) :6996-7006
[4]   TAT TRANS-ACTIVATES THE HUMAN IMMUNODEFICIENCY VIRUS THROUGH A NASCENT RNA TARGET [J].
BERKHOUT, B ;
SILVERMAN, RH ;
JEANG, KT .
CELL, 1989, 59 (02) :273-282
[5]   TAR-INDEPENDENT ACTIVATION OF THE HIV-1-LTR - EVIDENCE THAT TAT REQUIRES SPECIFIC REGIONS OF THE PROMOTER [J].
BERKHOUT, B ;
GATIGNOL, A ;
RABSON, AB ;
JEANG, KT .
CELL, 1990, 62 (04) :757-767
[6]   Inhibition of HIV-I replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex [J].
Biglione, Sebastian ;
Byers, Sarah A. ;
Price, Jason P. ;
Nguyen, Van Trung ;
Bensaude, Olivier ;
Price, David H. ;
Maury, Wendy .
RETROVIROLOGY, 2007, 4
[7]   A human splicing factor,SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat [J].
Brès, V ;
Gomes, N ;
Pickle, L ;
Jones, KA .
GENES & DEVELOPMENT, 2005, 19 (10) :1211-1226
[8]   SKIP Interacts with c-Myc and Menin to Promote HIV-1 Tat Transactivation [J].
Bres, Vanessa ;
Yoshida, Tomonori ;
Pickle, Loni ;
Jones, Katherine A. .
MOLECULAR CELL, 2009, 36 (01) :75-87
[9]   Progression through the RNA Polymerase II CTD Cycle [J].
Buratowski, Stephen .
MOLECULAR CELL, 2009, 36 (04) :541-546
[10]   The transcriptional inhibitors, actinomycin D and α-amanitin, activate the HIV-1 promoter and favor phosphorylation of the RNA polymerase IIC-terminal domain [J].
Cassé, C ;
Giannoni, F ;
Nguyen, VT ;
Dubois, MF ;
Bensaude, O .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (23) :16097-16106